Skip to content
2000
Volume 20, Issue 8
  • ISSN: 1574-8855
  • E-ISSN: 2212-3903

Abstract

Background

Stroke is a medical disorder defined by focal neurological deficits caused by vascular impairment (hemorrhage or infarction) in the CNS (Central Nervous System). Currently the second biggest cause of morbidity worldwide, strokes continue to be a deadly disease.

Objective

This review aimed to elucidate the stroke’s pathophysiology, both changeable and unchangeable risk factors associated with stroke, including prevention of stroke, its diagnosis, as well as treatment.

Methods

The articles were collected involving the research on stroke with the help of different sources, like PubMed, Science Direct, and Google. Many manuscripts were collected and analyzed, and the relevant ones were considered for the present manuscript.

Results

A brain CT scan has been found to be the first step in the management of Cerebrovascular Accident (CVA) in order to distinguish between ischemic and hemorrhagic stroke types. Beyond stroke classification, imaging has been observed to serve as a powerful tool for ruling out alternative diagnoses, predicting stroke outcomes, and facilitating appropriate treatment planning.

Conclusion

Stroke is the second foremost cause of death as well as disability worldwide, leading to substantial economic losses. Therefore, better treatment and improved management after stroke are a global health priority. Modifying risk factors can decrease the chances of occurrence of stroke. Also, correct diagnosis should be done to diagnose the presence of stroke and its type. Proper treatment should be provided, like perfusion, glucose management, antiplatelet therapy, antihypertensive therapy, stem cell therapy, neural response and rehabilitation, increased awareness, lifestyle changes, stress management, etc. Exercise can also help positively to reduce the chances of stroke.

Loading

Article metrics loading...

/content/journals/cdth/10.2174/0115748855309906240903050708
2024-09-19
2026-02-04
Loading full text...

Full text loading...

References

  1. ShakirR. The struggle for stroke reclassification.Nat. Rev. Neurol.201814844744810.1038/s41582‑018‑0036‑529959393
    [Google Scholar]
  2. RogerV.L. GoA.S. Lloyd-JonesD.M. AdamsR.J. BerryJ.D. BrownT.M. CarnethonM.R. DaiS. de SimoneG. FordE.S. FoxC.S. FullertonH.J. GillespieC. GreenlundK.J. HailpernS.M. HeitJ.A. HoP.M. HowardV.J. KisselaB.M. KittnerS.J. LacklandD.T. LichtmanJ.H. LisabethL.D. MakucD.M. MarcusG.M. MarelliA. MatcharD.B. McDermottM.M. MeigsJ.B. MoyC.S. MozaffarianD. MussolinoM.E. NicholG. PaynterN.P. RosamondW.D. SorlieP.D. StaffordR.S. TuranT.N. TurnerM.B. WongN.D. Wylie-RosettJ. Heart disease and stroke statistics--2011 update: a report from the American Heart Association.Circulation20111234e18e20910.1161/CIR.0b013e318200970121160056
    [Google Scholar]
  3. JohnsonC.O. NguyenM. RothG.A. NicholsE. AlamT. AbateD. Abd-AllahF. AbdelalimA. AbrahaH.N. Abu-RmeilehN.M.E. AdebayoO.M. AdeoyeA.M. AgarwalG. AgrawalS. AichourA.N. AichourI. AichourM.T.E. AlahdabF. AliR. Alvis-GuzmanN. AnberN.H. AnjomshoaM. ArablooJ. ArauzA. ÄrnlövJ. AroraA. AwasthiA. BanachM. BarbozaM.A. Barker-ColloS.L. BärnighausenT.W. BasuS. BelachewA.B. BelaynehY.M. BennettD.A. BensenorI.M. BhattacharyyaK. BiadgoB. BijaniA. BikbovB. Bin SayeedM.S. ButtZ.A. Cahuana-HurtadoL. CarreroJ.J. CarvalhoF. Castañeda-OrjuelaC.A. CastroF. Catalá-LópezF. ChaiahY. ChiangP.P-C. ChoiJ-Y.J. ChristensenH. ChuD-T. CortinovisM. DamascenoA.A.M. DandonaL. DandonaR. DaryaniA. DavletovK. de CourtenB. De la Cruz-GóngoraV. DegefaM.G. DharmaratneS.D. DiazD. DubeyM. DukenE.E. EdessaD. EndresM. FaraonE.J.A. FarzadfarF. FernandesE. FischerF. FlorL.S. GanjiM. GebreA.K. GebremichaelT.G. GetaB. GezaeK.E. GillP.S. GnedovskayaE.V. Gómez-DantésH. GoulartA.C. GrossoG. GuoY. GuptaR. Haj-MirzaianA. Haj-MirzaianA. HamidiS. HankeyG.J. HassenH.Y. HayS.I. HegazyM.I. HeidariB. HerialN.A. HosseiniM.A. HostiucS. IrvaniS.S.N. IslamS.M.S. JahanmehrN. JavanbakhtM. JhaR.P. JonasJ.B. JozwiakJ.J. JürissonM. KahsayA. KalaniR. KalkondeY. KamilT.A. KanchanT. KarchA. KarimiN. Karimi-SariH. KasaeianA. KassaT.D. KazemeiniH. KefaleA.T. KhaderY.S. KhalilI.A. KhanE.A. KhangY-H. KhubchandaniJ. KimD. KimY.J. KisaA. KivimäkiM. KoyanagiA. KrishnamurthiR.K. KumarG.A. LafranconiA. LewingtonS. LiS. LoW.D. LopezA.D. LorkowskiS. LotufoP.A. MackayM.T. MajdanM. MajdzadehR. MajeedA. MalekzadehR. ManafiN. MansourniaM.A. MehndirattaM.M. MehtaV. MengistuG. MeretojaA. MeretojaT.J. MiazgowskiB. MiazgowskiT. MillerT.R. MirrakhimovE.M. MohajerB. MohammadY. Mohammadoo-khorasaniM. MohammedS. MohebiF. MokdadA.H. MokhayeriY. MoradiG. MorawskaL. Moreno VelásquezI. MousaviS.M. MuhammedO.S.S. MuruetW. NaderiM. NaghaviM. NaikG. NascimentoB.R. NegoiR.I. NguyenC.T. NguyenL.H. NirayoY.L. NorrvingB. NoubiapJ.J. Ofori-AsensoR. OgboF.A. OlagunjuA.T. OlagunjuT.O. OwolabiM.O. PandianJ.D. PatelS. PericoN. PiradovM.A. PolinderS. PostmaM.J. PoustchiH. PrakashV. QorbaniM. RafieiA. RahimF. RahimiK. Rahimi-MovagharV. RahmanM. RahmanM.A. ReisC. RemuzziG. RenzahoA.M.N. RicciS. RobertsN.L.S. RobinsonS.R. RoeverL. RoshandelG. SabbaghP. SafariH. SafariS. SafiriS. SahebkarA. Salehi ZahabiS. SamyA.M. SantaluciaP. SantosI.S. SantosJ.V. Santric MilicevicM.M. SartoriusB. SawantA.R. SchutteA.E. SepanlouS.G. ShafieesabetA. ShaikhM.A. Shams-BeyranvandM. SheikhA. ShethK.N. ShibuyaK. ShigematsuM. ShinM-J. ShiueI. SiabaniS. SobaihB.H. SposatoL.A. SutradharI. SylajaP.N. SzoekeC.E.I. Te AoB.J. TemsahM-H. TemsahO. ThriftA.G. TonelliM. Topor-MadryR. TranB.X. TranK.B. TruelsenT.C. TsadikA.G. UllahI. UthmanO.A. VaduganathanM. ValdezP.R. VasankariT.J. VasanthanR. VenketasubramanianN. VosoughiK. VuG.T. WaheedY. WeiderpassE. WeldegwergsK.G. WestermanR. WolfeC.D.A. WondafrashD.Z. XuG. YadollahpourA. YamadaT. YatsuyaH. YimerE.M. YonemotoN. YousefifardM. YuC. ZaidiZ. ZamaniM. ZarghiA. ZhangY. ZodpeyS. FeiginV.L. VosT. MurrayC.J.L. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016.Lancet Neurol.201918543945810.1016/S1474‑4422(19)30034‑130871944
    [Google Scholar]
  4. Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association.Circulation201813712e67e49210.1161/CIR.0000000000000558
    [Google Scholar]
  5. Grupo de Estudio de las Enfermedades Cerebrovasculares de la Sociedad Espan ˜ola de Neurologı’aManejo del paciente con enfer medad cerebral aguda. Recomendaciones 1992.BarcelonaEDOS1992
    [Google Scholar]
  6. Pujadas CapmanyR. ArboixA. Casañas-MuñozR. Anguera-FerrandoN. Specific cardiac disorders in 402 consecutive patients with ischaemic cardioembolic stroke.Int. J. Cardiol.2004952-312913410.1016/j.ijcard.2003.02.00715193810
    [Google Scholar]
  7. GirijalaR.L. SohrabjiF. BushR.L. Sex differences in stroke: Review of current knowledge and evidence.Vasc Med22213514510.1177/1358863X16668263
    [Google Scholar]
  8. BoehmeA.K. EsenwaC. ElkindM.S.V. Stroke Risk Factors, Genetics, and Prevention.Circ. Res.2017120347249510.1161/CIRCRESAHA.116.30839828154098
    [Google Scholar]
  9. ReevesM.J. BushnellC.D. HowardG. GarganoJ.W. DuncanP.W. LynchG. KhatiwodaA. LisabethL. Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes.Lancet Neurol.200871091592610.1016/S1474‑4422(08)70193‑518722812
    [Google Scholar]
  10. Kelly-HayesM. Influence of age and health behaviors on stroke risk: lessons from longitudinal studies.J. Am. Geriatr. Soc.201058s2Suppl. 2S325S32810.1111/j.1532‑5415.2010.02915.x21029062
    [Google Scholar]
  11. AddoJ. AyerbeL. MohanK.M. CrichtonS. SheldenkarA. ChenR. WolfeC.D.A. McKevittC. Socioeconomic status and stroke: an updated review.Stroke20124341186119110.1161/STROKEAHA.111.63973222363052
    [Google Scholar]
  12. SandelM.E. WangH. TerdimanJ. HoffmanJ.M. CiolM.A. SidneyS. QuesenberryC. LuQ. ChanL. Disparities in stroke rehabilitation: results of a study in an integrated health system in northern California.PM R200911294010.1016/j.pmrj.2008.10.01219627870
    [Google Scholar]
  13. WangY.L. WuD. Nguyen-HuynhM.N. ZhouY. WangC.X. ZhaoX.Q. LiaoX.L. LiuL.P. WangY.J. Antithrombotic management of ischaemic stroke and transient ischaemic attack in China: A consecutive cross sectional survey.Clin. Exp. Pharmacol. Physiol.201037877578110.1111/j.1440‑1681.2010.05393.x20456429
    [Google Scholar]
  14. ChenJ.C. Geographic determinants of stroke mortality: role of ambient air pollution.Stroke201041583984110.1161/STROKEAHA.110.57847620339123
    [Google Scholar]
  15. IshiiM. [The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, and 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension].Jpn. J. Clin. Med.200058Suppl. 126727511026274
    [Google Scholar]
  16. ZhangF.L. GuoZ.N. WuY.H. LiuH.Y. LuoY. SunM.S. XingY.Q. YangY. Prevalence of stroke and associated risk factors: a population based cross sectional study from northeast China.BMJ Open201779e01575810.1136/bmjopen‑2016‑01575828871014
    [Google Scholar]
  17. KiefeC.I. WilliamsO.D. BildD.E. LewisC.E. HilnerJ.E. ObermanA. Regional disparities in the incidence of elevated blood pressure among young adults: the CARDIA study.Circulation19979641082108810.1161/01.CIR.96.4.10829286933
    [Google Scholar]
  18. MusukaT.D. WiltonS.B. TraboulsiM. HillM.D. Diagnosis and management of acute ischemic stroke: speed is critical.CMAJ20151871288789310.1503/cmaj.14035526243819
    [Google Scholar]
  19. BroughtonB.R.S. ReutensD.C. SobeyC.G. Apoptotic mechanisms after cerebral ischemia.Stroke2009405e331e33910.1161/STROKEAHA.108.53163219182083
    [Google Scholar]
  20. WoodruffT.M. ThundyilJ. TangS.C. SobeyC.G. TaylorS.M. ArumugamT.V. Pathophysiology, treatment, and animal and cellular models of human ischemic stroke.Mol. Neurodegener.2011611110.1186/1750‑1326‑6‑1121266064
    [Google Scholar]
  21. GelderblomM. LeypoldtF. SteinbachK. BehrensD. ChoeC.U. SilerD.A. ArumugamT.V. OrtheyE. GerloffC. TolosaE. MagnusT. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke.Stroke20094051849185710.1161/STROKEAHA.108.53450319265055
    [Google Scholar]
  22. SuhS.W. ShinB.S. MaH. Van HoeckeM. BrennanA.M. YenariM.A. SwansonR.A. Glucose and NADPH oxidase drive neuronal superoxide formation in stroke.Ann. Neurol.200864665466310.1002/ana.2151119107988
    [Google Scholar]
  23. QureshiA.I. AliZ. SuriM.F.K. ShuaibA. BakerG. ToddK. GutermanL.R. HopkinsL.N. Extracellular glutamate and other amino acids in experimental intracerebral hemorrhage: An in vivo microdialysis study.Crit. Care Med.20033151482148910.1097/01.CCM.0000063047.63862.9912771622
    [Google Scholar]
  24. WangJ. FieldsJ. ZhaoC. LangerJ. ThimmulappaR.K. KenslerT.W. YamamotoM. BiswalS. DoréS. Role of Nrf2 in protection against intracerebral hemorrhage injury in mice.Free Radic. Biol. Med.200743340841410.1016/j.freeradbiomed.2007.04.02017602956
    [Google Scholar]
  25. ArboixAdrià Infarction in the territory of the anterior cerebral artery: clinical study of 51 patients.BMC Neurol93010.1186/1471‑2377‑9‑3019589132
    [Google Scholar]
  26. FlahertyM.L. WooD. HaverbuschM. SekarP. KhouryJ. SauerbeckL. MoomawC.J. SchneiderA. KisselaB. KleindorferD. BroderickJ.P. Racial variations in location and risk of intracerebral hemorrhage.Stroke200536593493710.1161/01.STR.0000160756.72109.9515790947
    [Google Scholar]
  27. TestaiF.D. AiyagariV. Acute hemorrhagic stroke pathophysiology and medical interventions: blood pressure control, management of anticoagulant-associated brain hemorrhage and general management principles.Neurol. Clin.2008264963985, viii-ix10.1016/j.ncl.2008.06.00119026899
    [Google Scholar]
  28. AronowskiJ. ZhaoX. Molecular pathophysiology of cerebral hemorrhage: secondary brain injury.Stroke20114261781178610.1161/STROKEAHA.110.59671821527759
    [Google Scholar]
  29. MurphyS.J.X. WerringD.J. Stroke: causes and clinical features.Medicine202048956156610.1016/j.mpmed.2020.06.00232837228
    [Google Scholar]
  30. ArboixA. García-ErolesL. MassonsJ. OliveresM. TargaC. Lacunar infarcts in patients aged 85 years and older.Acta Neurol. Scand.20001011252910.1034/j.1600‑0404.2000.00005.x10660148
    [Google Scholar]
  31. Blood Pressure Management in Stroke.Hypertension20207661688169510.1161/HYPERTENSIONAHA.120.1465333040620
    [Google Scholar]
  32. BeddhuS. ChertowG.M. CheungA.K. CushmanW.C. RahmanM. GreeneT. WeiG. CampbellR.C. ConroyM. FreedmanB.I. HaleyW. HorwitzE. KitzmanD. LashJ. PapademetriouV. PisoniR. RiessenE. RosendorffC. WatnickS.G. WhittleJ. WheltonP.K. Influence of baseline diastolic blood pressure on effects of intensive compared with standard blood pressure control.Circulation2018137213414310.1161/CIRCULATIONAHA.117.03084829021322
    [Google Scholar]
  33. LuoY. WangX. MatsushitaK. WangC. ZhaoX. HuB. LiuL. LiH. LiuG. JiaQ. WangY. WangY. Associations between estimated glomerular filtration rate and stroke outcomes in diabetic versus nondiabetic patients.Stroke201445102887289310.1161/STROKEAHA.114.00538025116878
    [Google Scholar]
  34. PutaalaJ. HaapaniemiE. GordinD. LiebkindR. GroopP.H. KasteM. TatlisumakT. Factors associated with impaired kidney function and its impact on long-term outcome in young ischemic stroke.Stroke20114292459246410.1161/STROKEAHA.110.61272121737795
    [Google Scholar]
  35. TsagalisG. AkrivosT. AlevizakiM. ManiosE. StamatellopoulosK. LaggouranisA. VemmosK.N. Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortality.Nephrol. Dial. Transplant.200824119420010.1093/ndt/gfn47118728156
    [Google Scholar]
  36. OhS.W. BaekS.H. KimY.C. GooH.S. HeoN.J. NaK.Y. ChaeD.W. KimS. ChinH.J. Mild decrease in estimated glomerular filtration rate and proteinuria are associated with all-cause and cardiovascular mortality in the general population.Nephrol. Dial. Transplant.20122762284229010.1093/ndt/gfr62222140122
    [Google Scholar]
  37. Guidelines for Prevention and Management of Stroke Directorate General of Health Services Ministry of Health and Family Welfare Government of India2019
    [Google Scholar]
  38. www.ncbi.nlm.nih.gov
  39. DunbabinD.W. SandercockP A G. Investigation of acute stroke: what is the most effective strategy?Postgrad. Med. J.19916778525927010.1136/pgmj.67.785.2592062773
    [Google Scholar]
  40. MoreauF. AsdaghiN. ModiJ. GoyalM. CouttsS.B. Magnetic Resonance Imaging versus Computed Tomography in Transient Ischemic Attack and Minor Stroke: The More Υou See the More You Know.Cerebrovasc. Dis. Extra20133113013610.1159/00035502424403904
    [Google Scholar]
  41. PrasadK. KaulS. PadmaM.V. GorthiS.P. KhuranaD. BakshiA. Stroke management.Ann. Indian Acad. Neurol.2011145Suppl. 18210.4103/0972‑2327.8308421847335
    [Google Scholar]
  42. ChenJ. SunD. LiuM. ZhangS. RenC. Defibrinogen Therapy for Acute Ischemic Stroke: 1332 Consecutive Cases.Sci. Rep.201881948910.1038/s41598‑018‑27856‑629934579
    [Google Scholar]
  43. HaoZ. LiuM. CounsellC. WardlawJ.M. LinS. ZhaoX. Fibrinogen depleting agents for acute ischaemic stroke.Cochrane Libr.20123CD00009110.1002/14651858.CD000091.pub222419274
    [Google Scholar]
  44. LevyD.E. TrammelJ. WasiewskiW.W. Ancrod for acute ischemic stroke: a new dosing regimen derived from analysis of prior ancrod stroke studies.J. Stroke Cerebrovasc. Dis.2009181232710.1016/j.jstrokecerebrovasdis.2008.07.00919110140
    [Google Scholar]
  45. BarretoA.D. Intravenous thrombolytics for ischemic stroke.Neurotherapeutics20118338839910.1007/s13311‑011‑0049‑x21638138
    [Google Scholar]
  46. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke.N. Engl. J. Med.1995333241581158810.1056/NEJM199512143332401
    [Google Scholar]
  47. KülkensS. HackeW. Thrombolysis with alteplase for acute ischemic stroke: review of SITS-MOST and other Phase IV studies.Expert Rev. Neurother.20077778378810.1586/14737175.7.7.78317610385
    [Google Scholar]
  48. SeguraT. CallejaS. JordanJ. Recommendations and treatment strategies for the management of acute ischemic stroke.Expert Opin. Pharmacother.2008971071108510.1517/14656566.9.7.107118422467
    [Google Scholar]
  49. Abou-CheblA. BajzerC.T. KriegerD.W. FurlanA.J. YadavJ.S. Multimodal therapy for the treatment of severe ischemic stroke combining GPIIb/IIIa antagonists and angioplasty after failure of thrombolysis.Stroke200536102286228810.1161/01.STR.0000179043.73314.4f16179581
    [Google Scholar]
  50. QureshiA.I. Harris-LaneP. KirmaniJ.F. JanjuaN. DivaniA.A. MohammadY.M. SuarezJ.I. MontgomeryM.O. Intra-arterial reteplase and intravenous abciximab in patients with acute ischemic stroke: an open-label, dose-ranging, phase I study.Neurosurgery200659478979710.1227/01.NEU.0000232862.06246.3D16915119
    [Google Scholar]
  51. InvestigatorsI.I.T. The Interventional Management of Stroke (IMS) II Study.Stroke20073872127213510.1161/STROKEAHA.107.48313117525387
    [Google Scholar]
  52. MazighiM. MeseguerE. LabreucheJ. AmarencoP. Bridging therapy in acute ischemic stroke: a systematic review and meta-analysis.Stroke20124351302130810.1161/STROKEAHA.111.63502922529310
    [Google Scholar]
  53. JungS. StapfC. ArnoldM. Stroke unit management and revascularisation in acute ischemic stroke.Eur. Neurol.2015731-29810510.1159/00036521025413619
    [Google Scholar]
  54. LindsbergP.J. RoineR.O. Hyperglycemia in acute stroke.Stroke200435236336410.1161/01.STR.0000115297.92132.8414757880
    [Google Scholar]
  55. WadaS. YoshimuraS. InoueM. MatsukiT. ArihiroS. KogaM. KitazonoT. MakinoH. HosodaK. IharaM. ToyodaK. Outcome Prediction in Acute Stroke Patients by Continuous Glucose Monitoring.J. Am. Heart Assoc.201878e00874410.1161/JAHA.118.00874429650712
    [Google Scholar]
  56. HackamD.G. SpenceJ.D. Antiplatelet Therapy in Ischemic Stroke and Transient Ischemic Attack.Stroke201950377377810.1161/STROKEAHA.118.02395430626286
    [Google Scholar]
  57. StringbergA. CamdenR. QuallsK. NaqviS.H. Update on Dual Antiplatelet Therapy for Secondary Stroke Prevention.Mo. Med.2019116430330731527979
    [Google Scholar]
  58. WangY. WangY. ZhaoX. LiuL. WangD. WangC. WangC. LiH. MengX. CuiL. JiaJ. DongQ. XuA. ZengJ. LiY. WangZ. XiaH. JohnstonS.C. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack.N. Engl. J. Med.20133691111910.1056/NEJMoa121534023803136
    [Google Scholar]
  59. RobinsonT.G. PotterJ.F. FordG.A. BulpittC.J. ChernovaJ. JaggerC. JamesM.A. KnightJ. MarkusH.S. MistriA.K. PoulterN.R. Effects of antihypertensive treatment after acute stroke in the Continue Or Stop post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial.Lancet Neurol.20109876777510.1016/S1474‑4422(10)70163‑020621562
    [Google Scholar]
  60. PotterJ. MistriA. BrodieF. ChernovaJ. WilsonE. JaggerC. JamesM. FordG. RobinsonT. Controlling hypertension and hypotension immediately post stroke (CHHIPS)--a randomised controlled trial.Health Technol. Assess.2009139iii, ix-xi, 1-7310.3310/hta1309019208305
    [Google Scholar]
  61. HankeyG.J. Lowering blood pressure in acute stroke: the SCAST trial.Lancet2011377976769669810.1016/S0140‑6736(11)60163‑321316753
    [Google Scholar]
  62. BorlonganC.V. KoutouzisT.K. JordenJ.R. MartinezR. RodriguezA.I. PoulosS.G. FreemanT.B. McKeownP. CahillD.W. NishinoH. SanbergP.R. Neural transplantation as an experimental treatment modality for cerebral ischemia.Neurosci. Biobehav. Rev.1997211799010.1016/0149‑7634(95)00063‑18994211
    [Google Scholar]
  63. ParkY.J. NiizumaK. MokinM. DezawaM. BorlonganC.V. Cell-Based Therapy for Stroke.Stroke20205192854286210.1161/STROKEAHA.120.03061832811374
    [Google Scholar]
  64. AizmanI. VinodkumarD. McGroganM. BatesD. Cell Injury-Induced Release of Fibroblast Growth Factor 2: Relevance to Intracerebral Mesenchymal Stromal Cell Transplantations.Stem Cells Dev.201524141623163410.1089/scd.2015.008325873141
    [Google Scholar]
  65. DaoM. TateC.C. McGroganM. CaseC.C. Comparing the angiogenic potency of naïve marrow stromal cells and Notch-transfected marrow stromal cells.J. Transl. Med.20131118110.1186/1479‑5876‑11‑8123531336
    [Google Scholar]
  66. BaoX. WeiJ. FengM. LuS. LiG. DouW. MaW. MaS. AnY. QinC. ZhaoR.C. WangR. Transplantation of human bone marrow-derived mesenchymal stem cells promotes behavioral recovery and endogenous neurogenesis after cerebral ischemia in rats.Brain Res.2011136710311310.1016/j.brainres.2010.10.06320977892
    [Google Scholar]
  67. YooS.W. KimS.S. LeeS.Y. LeeH.S. KimH.S. LeeY.D. Suh-KimH. Mesenchymal stem cells promote proliferation of endogenous neural stem cells and survival of newborn cells in a rat stroke model.Exp. Mol. Med.200840438739710.3858/emm.2008.40.4.38718779651
    [Google Scholar]
  68. AizmanI. TateC.C. McGroganM. CaseC.C. Extracellular matrix produced by bone marrow stromal cells and by their derivative, SB623 cells, supports neural cell growth.J. Neurosci. Res.200987143198320610.1002/jnr.2214619530164
    [Google Scholar]
  69. ChoppM. LiY. ZhangZ.G. Mechanisms underlying improved recovery of neurological function after stroke in the rodent after treatment with neurorestorative cell-based therapies.Stroke2009403_suppl_1Suppl.S143S14510.1161/STROKEAHA.108.53314119064763
    [Google Scholar]
  70. CramerS.C. AbilaB. ScottN.E. SimeoniM. EnneyL.A. InvestigatorsM.S. Safety, pharmacokinetics, and pharmacodynamics of escalating repeat doses of GSK249320 in patients with stroke.Stroke20134451337134210.1161/STROKEAHA.111.67436623471268
    [Google Scholar]
  71. EmerickA.J. NeafseyE.J. SchwabM.E. KartjeG.L. Functional reorganization of the motor cortex in adult rats after cortical lesion and treatment with monoclonal antibody IN-1.J. Neurosci.200323124826483010.1523/JNEUROSCI.23‑12‑04826.200312832504
    [Google Scholar]
  72. PatelA.T. DuncanP.W. LaiS.M. StudenskiS. The relation between impairments and functional outcomes poststroke.Arch. Phys. Med. Rehabil.200081101357136310.1053/apmr.2000.939711030501
    [Google Scholar]
  73. DobkinB.H. The Clinical Science of Neurologic Rehabilitation.New York, NY, USAOxford University Press200310.1093/oso/9780195150643.001.0001
    [Google Scholar]
  74. DobkinB.H. Strategies for stroke rehabilitation.Lancet Neurol.20043952853610.1016/S1474‑4422(04)00851‑815324721
    [Google Scholar]
  75. IacoboniM. WoodsR.P. BrassM. BekkeringH. MazziottaJ.C. RizzolattiG. Cortical mechanisms of human imitation.Science199928654492526252810.1126/science.286.5449.252610617472
    [Google Scholar]
  76. A.Prevention of stroke: a global perspective Jeyaraj D Pandian, Seana L Gall, Mahesh P Kate, Gisele S Silva, Rufus O Akinyemi, Bruce I Ovbiagele, Pablo M Lavados, Dorcas B C Gandhi.Amanda G Thrift Lancet201839212691278
    [Google Scholar]
  77. HartR.G. PearceL.A. AguilarM.I. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.Ann. Intern. Med.20071461285786710.7326/0003‑4819‑146‑12‑200706190‑0000717577005
    [Google Scholar]
/content/journals/cdth/10.2174/0115748855309906240903050708
Loading
/content/journals/cdth/10.2174/0115748855309906240903050708
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test